Trials / Completed
CompletedNCT04451811
A PK Dose Proportionality Study of OPL-002 in Healthy Volunteers
A Pharmacokinetic Dose Proportionality Study of OPL-002 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Oppilan Pharma Ltd · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a single center, randomized, open-label, three-way crossover, single dose, pharmacokinetic dose proportionality study of oral OPL-002 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPL-002 | Spray dried dispersion and tablet formulation |
Timeline
- Start date
- 2020-09-07
- Primary completion
- 2021-02-24
- Completion
- 2021-02-24
- First posted
- 2020-06-30
- Last updated
- 2021-05-28
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04451811. Inclusion in this directory is not an endorsement.